School of Medicine
Showing 11,601-11,700 of 12,938 Results
-
Eline van Beest
Affiliate, School of Medicine - MDRP'S - Biodesign Program
BioEline founded the TUDelft spin-off and MedTech scale-up NightBalance in 2009 with a new therapy for sleep apnea. NightBalance was acquired by Philips in 2018. Currently, she Operating Partner at Thuja Capital and CEO of Hybridize Therapeutics, a spin-off from the LUMC that develops RNA-based therapies for kidney diseases. Besides that she is part of the Investment Committee of the Deep Tech Fund of EZ & InvestNL, the VGZ Voorop in Zorg Fonds and the Graduate Ventures Pre Seed Fund and is a member of the Supervisory Board of Yes!Delft (a leading tech incubator in Europe supporting 280 startups).
-
Laura van Dam
Postdoctoral Scholar, Immunology and Rheumatology
BioI am both trained as a biomedical researcher and medical doctor in internal medicine and strive to close the gap between the clinic and fundamental sciences with translational research. My focus is to study the mechanisms of autoimmune diseases and to translate research insights into therapeutics targeting autoimmunity. I have received my PhD in 2022 in Leiden for studying neutrophil extracellular traps and autoreactive B cells in renal autoimmune diseases. My postdoctoral research project in the Robinson lab focuses on investigating the underlying molecular mechanisms of the pathogenesis of ANCA-associated vasculitis. I particularly aim to identify potential microbial triggers and molecular mimicry in ANCA-associated vasculitis, by characterizing the nasal microbiome and sequencing T cells and B cells of ANCA-associated vasculitis patients.
-
Matt van de Rijn
Sabine Kohler, MD, Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.
-
Stephanie Van de Ven
Member, Stanford Cancer Institute
BioAs Deputy Director of the Canary Center at Stanford for Cancer Early Detection I broadly oversee its operations and research programs. The Canary Center is focused on developing in vitro and in vivo tools for early cancer detection and its research spans the areas of biomarker discovery, development of molecular imaging agents, development of new diagnostic and imaging devices, and mathematical modeling. In my position I facilitate the clinical translation of cancer diagnostic tools and I enable innovative interdisciplinary research. My research expertise includes leading phase I-II clinical trials to evaluate a newly developed optical breast imaging system in combination with a novel imaging agent. I gained valuable experience in clinical translation of medical devices and in testing new imaging agents for the first time in patients. My training as a Radiology resident was instrumental in my decision to focus on cancer early detection research, because it clearly confronted me with the problem that most cancer patients are being diagnosed too late. I expanded my knowledge on biomarker research by developing proteomics assays during my postdoctoral fellowship at Stanford, in conjunction with my continued work in optical and photoacoustic molecular imaging. In my current role, I work with the faculty of the Canary Center and the Molecular Imaging Program at Stanford, and am committed to advancing cancer research by applying my medical training, clinical knowledge, and research expertise to managing collaborative programs and contribute to the success of the Center and its faculty.
-
Laurens van de Wiel
Postdoctoral Scholar, Cardiovascular Medicine
BioI am a post-doctoral researcher at Stanford University under supervision of Matthew Wheeler and Stephen Montgomery. My research focuses on understanding the entire spectrum of genetic variation effects on protein function and structure in order to decipher molecular mechanisms of disease.
My post-doctoral work centers on developing novel software methodologies which combine multi-omics data to interpret the functional impact of genetic variants in undiagnosed patients. I am part of the Undiagnosed Disease Network (UDN) at Stanford Center for Undiagnosed Diseases (CUD), Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) consortium at GREGoR Stanford Site (GSS), and the Molecular Transducers of Physical Activity Consortium (MoTrPAC) at the Bioinformatics Center (BIC).
Before joining Stanford. I was received my Ph.D. in 2021 at the Radboud University Medical Center under supervision of Christian Gilissen, Gert Vriend, and Joris Veltman. I received my MSc degree in 2014 at Radboud University under supervision of Tom Heskes, Evgeni Levin, and Armand Paauw. Before my Ph.D, I worked as a Data Scientist at FLXone, where I developed machine learning solutions within a large-scale, real-time infrastructure.
Research
I am interested in a variety of topics in Bioinformatics and Computer Science. In particular, I am interested in the application of Artificial Intelligence and Statistical Modelling to analyse human (Rare) Mendelian Disease Genetics, Evolutionary Comparative Genomics, Protein Domain Homology, and Molecular Structures. -
Pieter van der Starre
Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
Neurophysiology and Monitoring,
Transesophageal Echocardiography -
Keith Van Haren, MD
Associate Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.
-
Krisa Van Meurs
Rosemarie Hess Professor, Emerita
Current Research and Scholarly InterestsMy research interests include persistent pulmonary hypertension of the newborn, hypoxic respiratory failure, inhaled nitric oxide therapy, ECMO, congenital diaphragmatic hernia, neonatal clinical trials, and the use of aEEG and NIRS to detect brain injury.
-
Roxanna Van Norman
Sr. Marketing Manager, Cardiothoracic Surgery
Current Role at StanfordSr. Marketing Manager, Stanford University School of Medicine, Department of Cardiothoracic Surgery
-
Max Van Puyvelde
Graduate, Medicine, School of Medicine
BioMax Van Puyvelde is a Visiting Student Researcher at BMIR, working under the supervision of Prof. Olivier Gevaert on foundation models and deep learning for 2D and 3D medical image analysis and segmentation. With a background in bioinformatics and machine learning, his work spans both academic and industry applications, including roles in AI-driven drug discovery and high-throughput medical imaging. Alongside research, Max has been involved in startup ventures, consulting, and scientific advising in the AI and healthcare space. He is currently completing his Master’s at Ghent University and will continue as a Visiting Researcher during his PhD, jointly at Stanford and Ghent University.
-
Capucine Van Rechem
Assistant Professor of Pathology (Pathology Research)
On Leave from 02/01/2026 To 03/15/2026Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.
-
Peter Johannes van Roessel
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD, PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment and Psychodynamic Psychotherapy Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology and co-leads a new adult outpatient ketamine-assisted psychotherapy clinic.
As Director of Clinical Research for the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive awareness ('insight') in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control and the processing of incongruity and error. Dr. van Roessel additionally contributes as co-investigator to the Suppes Exploratory Therapeutics Laboratory and to the Williams PANLab, on clinical trials advancing psychedelic-assisted psychotherapies and biomarker-informed precision medicine in depression and posttraumatic stress disorder.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Henk van Voorst
Postdoctoral Scholar, Radiology
BioDr. van Voorst is a postdoctoral scholar in Radiology studying the interfaces of artificial intelligence and neuroradiological imaging in stroke. Originally educated as an MD, Dr. van Voorst gained additional degrees in Finance and Data Science. As a PhD student, Dr. van Voorst focused on cost-effectiveness modeling and developed machine learning and deep learning algorithms with applications in acute ischemic stroke imaging. In his current research, Dr. van Voorst develops artificial intelligence algorithms to automatically extract information from arteries and veins in radiological stroke imaging.
-
Vance Vanier, M.D.
Clinical Assistant Professor, Emergency Medicine
Current Research and Scholarly InterestsPrimary and secondary prevention of disease through the use of preventive genomic medicine. Patients who have greater insight into their genetic risk for different diseases may change their lifestyles and decrease their probablity of succumbing to conditions such as diabetes and cardiovascular events. Personalized screening regimens for those at increased genetic risk, such as for colon cancer, is another important application worthy of validation.
-
Anubodh Sunny Varshney
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Anubodh Sunny Varshney is a Clinical Assistant Professor, Medical Director of Mechanical Circulatory Support, and Associate Director of the Fellowship Program in the Section of Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford. In addition to caring for patients with advanced heart disease, he is also a clinical researcher and works to identify patient groups that have sub-optimal outcomes with current therapies, define benchmark outcomes that next generation therapies should improve upon, and understand factors that influence adoption of novel drug and device therapies for cardiovascular disease.
Dr. Varshney earned a BS in biomedical engineering from Washington University in St. Louis and an MD from the University of Texas Southwestern Medical School. He completed residency in Internal Medicine and fellowship in Cardiovascular Medicine at Brigham & Women’s Hospital/Harvard Medical School and fellowship in Advanced Heart Failure, Transplant Cardiology, and Mechanical Circulatory Support at Stanford University.
Dr. Varshney also has experience advising multiple medical device, drug, and digital health start-ups and currently serves as a Venture Advisor at Broadview Ventures, a philanthropically-funded, mission-driven investment organization that invests in early-stage companies developing technologies that have the potential to improve outcomes for patients with cardiovascular disease or stroke. -
Kunal Varshneya
MD Student with Scholarly Concentration in Clinical Research, expected graduation Spring 2026
BioMedical student interested in orthopedic surgery and big data analytics.
-
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsAt Brainstorm: The Stanford Lab for Mental Health Innovation, we lead the way in digital well-being: translating cutting-edge research into practical solutions for healthier tech use.
We are first and foremost practicing physicians; we treat patients and families. Then, grounded by the foundational oath in medicine to “do no harm,” we help companies build products that prioritize user health with responsibility and care. Our work has shaped platforms used by millions—helping Pinterest design "compassionate search", guiding TikTok in healthy screen-time management, and partnering with ML Commons to establish the first mental health safety benchmarks for large language models (LLMs).
Brainstorm is further committed to “do good” by leveraging these technologies to build a healthier digital world. We advised Dove’s Self-Esteem Project and Real Beauty Prompt Playbook, which studied AI’s impact on beauty and set new digital standards of representation. Additionally, after sharing the results of research conducted with the Stanford Center for AI Safety on the ethics, efficacy, and safety of LLMs providing mental health support, we developed the “Framework for Healthy AI” to guide industry best practices in AI product innovation.
As we apply this expertise to improve users' daily lives, it’s clear that addressing digital intimacy presents unique challenges compared to traditional human relationships. This technology is still emerging, and we are all adapting to it in real-time as it evolves. The big question is: How can we help users cultivate healthy, safe digital relationships?
After seeing success with the Stanford Social Media Safety Plan, which reduced harmful digital behaviors among users, we are now designing the Stanford GenAI Psychological Safety Plan (GPS). The Stanford GPS is a tool to help individuals, tech developers, and policymakers navigate this new terrain and make informed decisions about AI’s role in mental health.
Check out the start of the Stanford GPS in Fortune: This 4-question quiz from Stanford psychiatrists can help protect from the dangers of AI. -
Minal Vasanawala
Clinical Associate Professor (Affiliated), Rad/Nuclear Medicine
Staff, Radiology - Diagnostic RadiologyCurrent Research and Scholarly InterestsPET/MRI, PETCT, and SPECT/CT applications in neuroimaging
Cardiac SPECT/CT and PET/CTA -
Shreyas Vasanawala, MD/PhD
William R. Brody Professor of Pediatric Radiology and Child Health
Current Research and Scholarly InterestsOur group is focused on developing new fast and quantitative MRI techniques.
-
Manuela Vasquez
Administrative Associate, Radiology
BioAs an Administrative Associate, I am dedicated to keeping scientists organized, prioritized and less stressed. I practice a streamlined and intuitive approach to assistance.
I am open-arms to opportunities that will broaden my horizon. A team player, willing to lead or follow, eager to learn and is self-motivated. Committed to excellence in service.
My philosophy centers around what role I can play in helping others find solutions. Enthusiastic and personable, my passion is to contribute, support, and make a difference. -
William J. Vasquez McTeigue
Life Science Research Professional 1, Surgery - Vascular Surgery
BioWilliam Vasquez McTeigue is conducting research in the lab of Katherine Hekman, MD, PhD, RPVI, FACS, where he applies induced pluripotent stem cells (iPSCs) to develop regenerative therapies for peripheral artery disease. His work bridges vascular surgery and stem-cell biology, with the goal of advancing treatments for patients with critical limb ischemia and other vascular disorders.
Beyond his current research, William is interested in cardiovascular innovation and translational medicine, aiming to pursue a career at the intersection of surgery, engineering, and regenerative biology. -
Girija Vasudevan
PDM Senior Manufacturing Specialist, Stanford Laboratory for Cell and Gene Medicine
Current Role at StanfordGirija is a Process Development and Manufacturing Specialist to work on cell and gene therapy applications for rare immunological diseases and cancers, which involves manufacturing clinical-grade products for Stem cell and T-cell therapy.
-
Cristiana Vattuone, PhD
Clinical Research Associate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Vattuone is a clinician and researcher for the Autism and Developmental Disorders Research Program in the Division of Child Psychiatry and Behavioral Sciences. Dr. Vattuone's expertise includes clinical and neuropsychological assessment of autism spectrum disorder and associated genetic conditions. Dr. Vattuone received her Ph.D. in Human Development and Psychology from the University of California, Los Angeles with specialized training in evidence-based interventions. Dr. Vattuone’s research efforts focus on the early identification, diagnosis, and treatment of infants and toddlers, developmental trajectories, and the role of the family in supporting positive outcomes. Her dedication to research, treatment, and training continues at ADDRP to support individuals with autism spectrum disorder and their families.
-
Alun Vaughan Jackson
Postdoctoral Scholar, Genetics
BioCollaborative postdoctoral fellow between the groups of Prof. Michael Bassik (Stanford) and Dr Andreas Puschnik (CZ Biohub) interested in host-virus interactions with the innate immune system.
-
Zackary Vaughn, MD
Clinical Assistant Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsHip Arthroscopy in the Treatment of Femoroacetabular Impingement and Labral Tears
Anterior Cruciate Ligament Reconstruction and Revision Techniques -
Aditya Vaze
Affiliate, Neurology & Neurological Sciences
BioDr. Vaze is a board-certified, fellowship-trained cardiologist with Stanford Medicine Partners Cardiology Castro Valley, Stanford Health Care Emeryville, and Heart & Vascular Clinic Pleasanton. He holds board certifications in cardiovascular disease, adult echocardiography, cardiac CT, nuclear cardiology, and internal medicine.
Dr. Vaze prides himself on providing comprehensive, patient-focused care and acting as a partner in navigating the complexities of a heart condition diagnosis. He focuses on evidence-based medicine, the latest diagnostic tools and testing, and most of all, his patients’ needs. Dr. Vaze wants his patients to actively participate in their care, as he believes it leads to the best outcomes and to more personalized care.
Dr. Vaze has a strong interest in improving quality and business processes to deliver efficient, streamlined care. He has worked on interventions for increasing safety and satisfaction across multiple hospital systems, including leading local projects focused on optimizing coronary angiography patient workflows. Dr. Vaze has also participated in national projects including the Million Hearts® Cardiovascular Disease Risk Reduction Model to reduce cardiovascular disease risk.
Dr. Vaze’s clinical research interests include atrial fibrillation and predicting cardiac mortality. Dr. Vaze has published his work in many peer-reviewed journals, including PLOS One, Clinical Cardiology, Journal of the American College of Cardiology, and Current Cardiology Reports. He has also coauthored many abstracts for the American Heart Association Scientific Sessions.
Dr. Vaze is a member of the American College of Cardiology, the American Heart Association, the American Society of Echocardiography, and the American Society of Nuclear Cardiology. -
Shivam Vedak
Clinical Assistant Professor, Medicine
BioShivam Vedak, MD, MBA, is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. He earned his Bachelor of Science in Biology-Neuroscience from the Schreyer Honors College at The Pennsylvania State University, followed by a dual MD/MBA from the University of Illinois at Chicago (UIC). He completed his residency in Internal Medicine at UIC, where he was honored as the institution’s American College of Physicians Outstanding Resident of the Year in 2022, and subsequently completed a fellowship in Clinical Informatics at Stanford.
Clinically, Dr. Vedak practices as a surgical co-management hospitalist at Stanford Health Care (SHC). His academic and operational work centers on the practical integration of generative artificial intelligence (AI) into clinical workflows, ranging from safe and effective deployment and monitoring to the broader education of healthcare workers on these rapidly evolving technologies. He is frequently invited to speak at national conferences, academic institutions, and professional events, offering both engaging interactive workshops and structured didactic sessions on the fundamentals of large language models (LLMs) and evidence-based prompting techniques. -
Anand Veeravagu, MD, FAANS, FACS
Associate Professor of Neurosurgery and, by courtesy, of Orthopaedic Surgery
Current Research and Scholarly InterestsThe focus of my laboratory is to utilize precision medicine techniques to improve the diagnosis and treatment of neurologic conditions. From traumatic brain injury to spinal scoliosis, the ability to capture detailed data regarding clinical symptoms and treatment outcomes has empowered us to do better for patients. Utilize data to do better for patients, that’s what we do.
Stanford Neurosurgical Ai and Machine Learning Lab
http://med.stanford.edu/neurosurgery/research/AILab.html -
Jaqueline Velazquez
Senior Administrative Associate, Radiology
Current Role at StanfordSupporting RSL Faculty:
Dr. Ennis, PhD
Dr. Setsompop, PhD
Dr. McNab, PhD -
Gabriel Velez, MD, PhD
Postdoctoral Scholar, Ophthalmology
BioGabriel Velez is a PGY3 ophthalmology resident at Stanford. He received his bachelor’s degree in molecular biology from Winona State University in 2014. He completed his MD and PhD degrees at the University of Iowa. His PhD research focused on studying the structure of the calpain-5 (CAPN5) protein and its role in the development of Neovascular Inflammatory Vitreoretinopathy (NIV), a rare blinding eye disease. His research interests include translational proteomics, retinal disease, ocular oncology, structural biology, biophysical chemistry, drug design, and bioinformatics.
-
Jenny Lymary Veliz-Urzua, DNP, FNP-BC
Affiliate, Surgery - General Surgery
BioJenny L. Veliz-Urzua, DNP, FNP-BC is Nurse Practitioner for GI Surgical-Oncology at Stanford Health Care Center. She graduated with her Family Nurse Practitioner (FNP) degree from Yale University School of Nursing in 2006. Her area of clinical practice includes hepatobiliary, pancreas, gastrointestinal and peritoneal malignancies. She has worked closely with Dr. Byrne Lee, Program Director for Regional Cancer Therapies, to optimize HIPEC patient care experience.
